Seema Bhat
Clinical trials sponsored by Seema Bhat, explained in plain language.
-
New drug aims to fight cancer without harming the heart
Disease control Recruiting nowThis study is testing a cancer drug called acalabrutinib for patients with chronic lymphocytic leukemia (CLL). It focuses on patients who had to stop a similar drug, ibrutinib, because of heart-related side effects. The main goal is to see if switching to acalabrutinib can effect…
Phase: PHASE2 • Sponsor: Seema Bhat • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New vaccine strategy could better protect cancer patients from dangerous infections
Prevention Recruiting nowThis study is testing whether giving pneumococcal vaccines more frequently provides better protection for people with chronic lymphocytic leukemia (CLL). The trial will compare the standard 5-year vaccination schedule against more frequent yearly vaccinations in 80 CLL patients w…
Phase: PHASE2 • Sponsor: Seema Bhat • Aim: Prevention
Last updated Mar 27, 2026 12:39 UTC